<i>SERPINB9</i> is commonly amplified and high expression in cancer cells correlates with poor immune checkpoint blockade responseSofía Ibáñez-Molero, Daniel S. Peeper, Weiwei Zhong et al.|OncoImmunology|2022Cited by 33
An adverse tumor-protective effect of IDO1 inhibitionJuliana C.N. Kenski, Daniel S. Peeper, Ton N. Schumacher et al.|Cell Reports Medicine|2023Cited by 32
Multimodal stimulation screens reveal unique and shared genes limiting T cell fitnessChun‐Pu Lin, Daniel S. Peeper, David W. Vredevoogd et al.|Cancer Cell|2024Cited by 17